This content is from: Portfolio David Tepper Hates Social Media, but Still Loves FAANG Stocks Speaking at Robin Hood’s annual conference, the Appaloosa founder opined on his favorite stocks, ESG, and China. By Julie Segal June 17, 2021
This content is from: Premium Hedge Funds Cheer Uber’s Surge A large group of well-known hedge funds made big second-quarter bets on the ride-hailing company. Will they be rewarded? By Stephen Taub September 21, 2021
This content is from: Portfolio Proxy Advisors Back Allergan Over Appaloosa in Latest Scuffle Appaloosa wants to replace Allergan’s chairman and install an independent pharmaceutical executive in that role. ISS and Glass Lewis recommend that shareholders vote against it. By Alicia McElhaney April 15, 2019
This content is from: Premium Mergers Boost David Tepper’s Appaloosa Tepper’s fund and other hedge funds are benefiting from this week’s deals to acquire Caesars and Allergan. By Stephen Taub June 25, 2019
This content is from: Premium Appaloosa Alum Matthew Knauer’s Nokota Mounts a Comeback After a tough year including a co-founder’s departure and stark losses, Nokota matched its best year ever in 2019. By Stephen Taub January 29, 2020
This content is from: Premium David Tepper’s Appaloosa Sharply Boosts Bet on U.S. Stocks The eclectic investment firm increased the size of its stock portfolio for the first time in four quarters. By Stephen Taub May 17, 2019
